HBW Advisory Services’s Haemonetics HAE Stock Holding History

HBW Advisory Services’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,857	Closed	-$213K	–	122
2019 Q4	$213K	Buy	+1,857	New	+$225K	0.12%	128

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

HBW Advisory Services's HAE Position: Q1 2020 in Review

HBW Advisory Services sold out of Haemonetics (HAE) in Q1 2020, closing a stake of 1,857 shares — an estimated $213K sold.

HBW Advisory Services first reported a position in HAE in Q4 2019 and held it in 1 quarter. The position peaked at $213K in Q4 2019. 269 funds tracked by Wall St. Rank hold HAE as of Q1 2020.

HBW Advisory Services reported no remaining Haemonetics position as of Q1 2020 after selling out during the quarter.
HBW Advisory Services sold 1,857 Haemonetics shares in Q1 2020, an estimated $213K.
HBW Advisory Services first reported a position in Haemonetics in Q4 2019 and held it in 1 quarter.
HBW Advisory Services's Haemonetics position peaked at $213K in Q4 2019.
269 funds tracked by Wall St. Rank held Haemonetics as of Q1 2020.

Based on HBW Advisory Services's 13F filing for Q1 2020, filed 30 Apr 2020.